Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

Presentation TCT 2021

Femoral Venous Pathway Obstruction: Alternate Vascular Approaches

Presenter: John Rhodes

November 06, 2021

Presentation Cardiovascular Interventions 2018

PFO Closure to Prevent Recurrent Cryptogenic Stroke

Presenter: Matthew J. Price

October 26, 2018

Presentation The Structural Heart Disease Summit 2018

How Should Physicians and Patients Choose Between Alternative Therapies for NVAF and Iatrogenic Stroke? The Essence of Shared Decision-making

Presenter: James B. Hermiller Jr, Saibal Kar, Megan Coylewright

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

Data Deliverance: Updated PFO Closure for Cryptogenic Stroke Clinical Trial Review and Guidelines

Presenter: John D. Carroll, Brij Maini, Lars Sondergaard

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

An Integrated Strategy to Prevent Both Ischemic and Hemorrhagic Strokes

Presenter: Robert J. Sommer, Brian K. Whisenant, Rajan Gadhia

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

Pharmacologic Agents to Prevent Stroke in Nonvalvular Atrial Fibrillation and PFO: Evidence and Real-world Practices

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Gregg W. Stone

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Cardioembolic Stroke: Scope, Etiologies, Guidelines, and Uncertainties

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Rajan Gadhia

June 22, 2018

Presentation Controversies and Advances 2017

PFO Closure - Close Them All?

Presenter: Saibal Kar

November 16, 2017

Presentation TCT 2017

Case Study #3 Resolution: How We Treated, and Long-term Outcome

Presenter: Lee N. Benson, Megan Coylewright, David L. Tirschwell

November 01, 2017

Presentation TCT 2017

Case Study #3 Introduction: To Close or Not to Close?

Presenter: Lee N. Benson, Megan Coylewright, David L. Tirschwell

November 01, 2017

Presentation TCT 2017

Case Study #2 Resolution: How We Treated, and Long-term Outcome

Presenter: Lee N. Benson, Megan Coylewright, Michael J. Mullen

November 01, 2017

Presentation TCT 2017

Case Study #2 Introduction: To Close or Not to Close?

Presenter: Lee N. Benson, Megan Coylewright, Michael J. Mullen

November 01, 2017

Presentation TCT 2017

Case Study #1 Resolution: How We Treated, and Long-term Outcome

Presenter: Lee N. Benson, Megan Coylewright, Steven L. Goldberg

November 01, 2017

Presentation TCT 2017

Case Study #1 Introduction: To Close or Not to Close?

Presenter: Lee N. Benson, Megan Coylewright, Steven L. Goldberg

November 01, 2017

Presentation TCT 2017

What is Appropriate Evaluation of Cryptogenic Stroke, and When is a Hypercoagulability Work-up Needed?

Presenter: Lee N. Benson, Megan Coylewright, David E. Thaler

November 01, 2017

Presentation TCT 2017

PFO Closure in Cryptogenic Stroke

Presenter: David Hildick-Smith, Lars Sondergaard

October 29, 2017

Presentation LAA 2017

Patient Selection and Outcomes of PFO Closure in Idiopathic Stroke: Lessons From RESPECT and Worldwide Registries

Presenter: David E. Thaler

July 22, 2017

Presentation

CLOSE: Closure of PFO, Oral Anticoagulants, or Antiplatelet Therapy to Prevent Stroke Recurrence

May 24, 2017

Presentation

PFO Closure in the Gore REDUCE Clinical Trial

May 24, 2017

Presentation SIF 2017

PFO Closure for Cryptogenic Stroke Choose your Patients Well

Presenter: James A. Goldstein

March 09, 2017

Advertisement

Femoral Venous Pathway Obstruction: Alternate Vascular Approaches

PFO Closure to Prevent Recurrent Cryptogenic Stroke

How Should Physicians and Patients Choose Between Alternative Therapies for NVAF and Iatrogenic Stroke? The Essence of Shared Decision-making

Data Deliverance: Updated PFO Closure for Cryptogenic Stroke Clinical Trial Review and Guidelines

An Integrated Strategy to Prevent Both Ischemic and Hemorrhagic Strokes

Pharmacologic Agents to Prevent Stroke in Nonvalvular Atrial Fibrillation and PFO: Evidence and Real-world Practices

Cardioembolic Stroke: Scope, Etiologies, Guidelines, and Uncertainties

PFO Closure - Close Them All?

Case Study #3 Resolution: How We Treated, and Long-term Outcome

Case Study #3 Introduction: To Close or Not to Close?

Case Study #2 Resolution: How We Treated, and Long-term Outcome

Case Study #2 Introduction: To Close or Not to Close?

Case Study #1 Resolution: How We Treated, and Long-term Outcome

Case Study #1 Introduction: To Close or Not to Close?

What is Appropriate Evaluation of Cryptogenic Stroke, and When is a Hypercoagulability Work-up Needed?

PFO Closure in Cryptogenic Stroke

Patient Selection and Outcomes of PFO Closure in Idiopathic Stroke: Lessons From RESPECT and Worldwide Registries

CLOSE: Closure of PFO, Oral Anticoagulants, or Antiplatelet Therapy to Prevent Stroke Recurrence

PFO Closure in the Gore REDUCE Clinical Trial

PFO Closure for Cryptogenic Stroke Choose your Patients Well

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content